Purchase Order 75D30123P16389

Award Date 4/19/23
Potential Completion Date 6/13/23
Potential Value $25K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
East Yaphank, NY 11967, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to CD Biosciences Inc., a small business research product supplier and contract research organization, is for CD BIOSCIENCES INCRNA DATA ANALYSIS services. The $4,998.00 firm fixed-price purchase order was awarded on February 2, 2018 by the Southeast Area division of a civilian federal agency, with a completion date of February 23, 2018. CD Biosciences, operating under multiple divisions including Creative Biomart, Creative Biolabs, CD Genomics, and Profacgen, has...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to CD Biosciences Inc., doing business as Creative Biomart, for metagenomic shotgun sequencing services. The contract has a potential value of $20,000.00 and a completion date of March 20, 2025. CD Biosciences Inc. is a research product supplier and contract research organization that has previously provided a...
This federal contract award, valued at $15,575.00, was issued by the National Heart Lung and Blood Institute (NHLBI) to CD Biosciences Inc., a small business research product supplier and contract research organization. The contract is for the provision of RNA sequencing services for 115 samples, with a completion date of May 22, 2020. The contract is a firm fixed-price purchase order, and is designated as a total small business set-aside. CD Biosciences Inc. operates under multiple divisions,...
This is a firm-fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Pacific Biosciences of California, Inc. for $84,000.00. The contract is for a service plan and has no set-aside designation. Pacific Biosciences is the original equipment manufacturer for their proprietary single molecule, real-time (SMRT) DNA/RNA sequencing technology. This contract award is likely part of Pacific Biosciences' broader work providing specialized sequencing...
The U.S. government has awarded a $22,890.00 Firm Fixed Price purchase order contract to CD Biosciences Inc., doing business as Creative Biomart, a small business provider of biotechnology services. The contract, which is a set-aside for small businesses, is for the "SEQUENCING CMBS INSECT PROGRAM" and has an ultimate completion date of July 30, 2024. CD Biosciences Inc. is a small business that specializes in genomic sequencing, bioinformatics analysis, and other molecular biology...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $159,300.00 firm fixed price purchase order to Life Technologies Corporation, a for-profit provider of biomedical research and genetic analysis tools and technologies. The contract, which does not have a set-aside designation, is for the delivery of specialized gene expression products and services, including "TAC CARDS", to support the CDC's disease research, healthcare programs, and...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $148,000.00 contract is for the delivery of products and services to support the CDC's biomedical research, public health, and healthcare programs. This includes DNA/RNA extraction kits, next-generation sequencing, digital PCR systems, sample preparation equipment, bioinformatics...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $71,550.00 Firm Fixed Price Purchase Order to VWR International LLC for the delivery of DNA Preparation Kits. This award was made under the CDC's Division of Viral Diseases (DVD), National Center for Immunization and Respiratory Diseases (NCIRD), Division of Bacterial Diseases (DBD) program (major program code: CDC\DDID\NCIRD\DBD\R - CDC\DDID\NCIRD\DBD\RDB (HCVGGB)). The contract has an ultimate completion date of July 2, 2024...
CD Biosciences Inc., doing business as Creative Biomart, Creative Biolabs, CD Genomics, and Profacgen Division, has been awarded a $15,000 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide creative diagnostics glycoproteins and nucleoproteins. The contract has a period of performance from September 22, 2023 through December 29, 2023, with all work to be conducted by the prime contractor in East Yaphank, New...
This contract award is to Pacific Biosciences of California, Inc., a for-profit manufacturer, for the delivery of their Sequel and Sequel II DNA/RNA sequencing platforms and associated consumables to the Centers for Disease Control and Prevention (CDC). The $250,000.00 firm-fixed price purchase order has a performance period ending on December 31, 2025. Pacific Biosciences has established itself as a key supplier of specialized sequencing solutions to various federal agencies, as evidenced by...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to CD Biosciences Inc. for DNA QC services. The contract has a potential value of $24,750.00 and a completion date of June 13, 2023. CD Biosciences Inc. is a research product supplier and contract research organization that provides molecular biology services, including genomic analysis, to government agencies such as NIH, FDA, USDA, CDC, and VA. The work will be performed at the company's facility in East Yaphank, New York. This contract does not have a set-aside designation.

Generated 3/27/24, 10:52 AM